Table 3.
Women | Men | |
---|---|---|
Use of thyroxine | ||
Weight gain 0–14 ya | 1.42, 1.09–1.84 | 1.32, 0.60–2.86 |
Height gain 2–14 ya | 1.07, 0.82–1.41 | 0.98, 0.45–2.11 |
Overweight or Obese at 14 yb | 1.36, 0.80–2.31 | 3.50, 1.16–10.61 |
High anti-TPO antibodies (>100 IU/ml) | ||
Weight gain 0–14 ya | 1.71, 1.23–2.37 | 0.97, 0.46–2.03 |
Height gain 2–14 ya | 1.00, 0.73–1.39 | 1.17, 0.57–2.40 |
Overweight or Obese at 14 yb | 2.05, 1.12–3.76 | 1.16, 0.38–3.51 |
Statistically significant (P < .05) associations are highlighted in bold type.
Odds ratios (95% CI) are shown per +1 U gain in weight SDS between 0–14 yr, and per +1 U gain in height SDS between 2–14 yr. Models included both weight gain and height gain, and were also adjusted for birth weight SDS and height SDS at age 2 yr.
Odds ratios (95% CI) are shown for overweight or obesity at age 14 yr (defined as BMI >90th centile according to sex-specific internal references) vs. all others.